Rocket Pharmaceuticals, Inc. Regulatory Liability, Current
Rocket Pharmaceuticals, Inc. (RCKT) had Regulatory Liability, Current of $0 as of 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:RegulatoryLiabilityCurrent · last filed 2024-02-27
- 2023-12-31: Regulatory Liability, Current $0.00.
- 2023-09-30: Regulatory Liability, Current $0.00.
- 2023-06-30: Regulatory Liability, Current $597.00K.
- 2023-03-31: Regulatory Liability, Current $597.00K.
| Period end | Regulatory Liability, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-27 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 |
| 2023-06-30 | $597.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $597.00K 10-Q · filed 2023-05-05 |
| 2022-12-31 | $597.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $597.00K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $597.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $597.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $597.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $597.00K 10-Q · filed 2021-11-05 |
| 2021-06-30 | $597.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $597.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $590.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $583.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $576.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $569.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $562.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $555.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $548.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $541.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $534.00K 10-K · filed 2020-03-06 |
| 2018-09-30 | $527.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $520.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $513.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |